Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
International Journal of Particle Therapy|May 11, 2023
Dosimetric Comparison of Intensity-Modulated Radiation Therapy (IMRT) and Intensity-Modulated Proton Therapy (IMPT) for a Novel Oral Tongue Avoidance Concept in Low-Risk Squamous Cell Carcinoma of the Oral TongueRobert H Press, Lei Hu, Sheng Huang, et al.
Cancers|June 10, 2022
Management of Older Adults with Locally Advanced Head and Neck CancerDaniel R Dickstein, Eric J Lehrer, Kristin Hsieh, et al.
The Laryngoscope|June 18, 2022
High Failure Rates in Young Nonsmoker Nondrinkers With Squamous Cell Carcinoma of the Oral TongueBrianna M Jones, Dillan F Villavisanis, Eric J Lehrer, et al.
Head & Neck|October 17, 2020
Ipsilateral radiation for squamous cell carcinoma of the tonsil: American Radium Society appropriate use criteria executive summaryC Jillian Tsai, Thomas J Galloway, Danielle N Margalit, et al.
Cancers|October 16, 2024
The Potential and Challenges of Proton FLASH in Head and Neck Cancer ReirradiationChingyun Cheng, Liming Xu, Hao Jing, et al.
Head & Neck|January 21, 2021
Redefining risk of contralateral cervical nodal disease in early stage oropharyngeal cancer in the human papillomavirus eraAndrew W Smith, Matthew Gallitto, Eric J Lehrer, et al.
The Oncologist|March 6, 2021
De-Escalated Adjuvant Therapy After Transoral Robotic Surgery for Human Papillomavirus-Related Oropharyngeal Carcinoma: The Sinai Robotic Surgery (SIRS) TrialBrett A Miles, Marshall R Posner, Vishal Gupta, et al.
JAMA Otolaryngology-- Head & Neck Surgery|September 19, 2024
Diagnostic Accuracy of Circulating Tumor HPV DNA Testing in Patients With a Lateral Neck MassRocco M Ferrandino, Joshua Barlow, Brandon Gold, et al.
Anticancer Research|July 31, 2014
Postoperative radiation therapy for parotid pleomorphic adenoma with close or positive margins: treatment outcomes and toxicitiesShyamal Patel, Waleed F Mourad, Chengtao Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 2019
A Phase 1 Study of Afatinib in Combination with Postoperative Radiation Therapy with and Without Weekly Docetaxel in Intermediate- and High-Risk Patients with Resected Squamous Cell Carcinoma of the Head and NeckDanielle N Margalit, Robert I Haddad, Roy B Tishler, et al.
Pageof 9